Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print May 21, 2009, doi: 10.1161/CIRCRESAHA.108.191387
A more recent version of this article appeared on June 19, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/12/1373    most recent
CIRCRESAHA.108.191387v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schroder, E.
Right arrow Articles by Satin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schroder, E.
Right arrow Articles by Satin, J.
Related Collections
Right arrow Other myocardial biology
Right arrow Other heart failure
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Hypertrophy
Right arrow Physiological and pathological control of gene expression

Submitted on November 18, 2008
Revised on April 29, 2009
Accepted on May 12, 2009

The L-Type Calcium Channel C Terminus Autoregulates Transcription

Elizabeth Schroder ; Miranda Byse ; and Jonathan Satin *

From the Department of Physiology, University of Kentucky, Lexington.

* To whom correspondence should be addressed. E-mail: jsatin1{at}uky.edu.

Calcium homeostasis is critical for cardiac myocyte function and must be tightly regulated. The guiding hypothesis of this study is that a carboxyl-terminal cleavage product of the cardiac L-type calcium channel (CaV1.2) autoregulates expression. First, we confirmed that the CaV1.2 C terminus (CCt) is cleaved in murine cardiac myocytes from mature and developing ventricle. Overexpression of full-length CCt caused a 34±8% decrease of CaV1.2 promoter activity, and truncated CCt caused an 80±3% decrease of CaV1.2 promoter (n=12). The full-length CCt distributes into cytosol and nucleus. A deletion mutant of CCt has a greater relative affinity for the nucleus than full-length CCt, and this is consistent with increased repression of CaV1.2 promoter activity by truncated CCt. Chromatin immunoprecipitation analysis revealed that CCt interacts with the CaV1.2 promoter in adult ventricular cardiac myocytes at promoter modules containing Nkx2.5/Mef2, C/EBp, and a cis regulatory module. The next hypothesis tested was that CCt contributes to transcriptional signaling associated with cellular hypertrophy. We explored whether fetal cardiac myocyte CaV1.2 was regulated by serum in vitro. We tested atrial natriuretic factor promoter activity as a positive control and measured the serum response of CaV1.2 promoter, protein, and L-type current (ICa,L) from fetal mouse ventricular myocytes. Serum increased atrial natriuretic factor promoter activity and cell size as expected. Serum withdrawal increased CaV1.2 promoter activity, mRNA, and ICa,L. Moreover, serum withdrawal decreased the relative nuclear localization of CCt. A combination of promoter deletion mutant analyses, and the response of promoter mutants to serum withdrawal support the conclusion that CCt, a proteolytic fragment of CaV1.2, autoregulates CaV1.2 expression in cardiac myocytes. These data support the novel mechanism that a mobile segment of CaV1.2 links Ca handling to nuclear signaling.


Key words: L-type Ca2+ channels • L-type Ca2+ current • Ca2+ channels • Ca2+ regulation • transcriptional regulation